Comparison of Higher-Dose Intradermal Hepatitis B Vaccination to Standard Intramuscular Vaccination of Healthcare Workers

Infection Control

Volumn 21, Issue 4, 2000, Pages 264-269

  Henderson, Elizabeth A ^a   Louie, Thomas J ^a   Ramotar, Karam ^a   Ledgerwood, Donna ^a   Hope, Karen Myrthu ^a   Kennedy, Agnes ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DOSE RESPONSE; FEMALE; HEPATITIS B; HOSPITAL PERSONNEL; HUMAN; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; COST-BENEFIT ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; PERSONNEL, HOSPITAL; VACCINES, DNA;

EID: 0034169222     PISSN: 01959417     EISSN: 23279451     Source Type: Journal    
DOI: 10.1086/501756     Document Type: Article

References (21)

1. Bryan J, Iqbal M, Sjogren M, et al. Low-dose intradermal recombinant hepatitis B vaccine. ICAAC. Houston, TX; September 1989;133. Abstract 196.
2. Lancaster D, Elam S, Kaiser AB. Immunogenicity of the intradermal route of hepatitis B vaccination with the use of recombinant hepatitis B vaccine. Am J Infect Control 1989;17:126–129.
3. Bryan JP, Sjogren M, Iqbal M, Khattak AR, Nabi S, Ahmed A, et al. Comparative trial of low-dose, intradermal, recombinant- and plasma-based hepatitis B vaccines. J Infect Dis 1990;162:789–793.
4. Heijtink RA, Breukers AA, den Hartigh G, Schepman RW, Schmitz I, Schalm SW, et al. Low-dose intradermal vaccination against hepatitis B in mentally retarded patients. Vaccine 1988;6:59–61.
5. McMaster KR III, Roper JK, Carter JB. Intradermal hepatitis B vaccination in a 300-bed primary care hospital: experience with a recombinant vaccine in a four-dose schedule. Am J Infect Control 1993;21:283–288.
6. Parish DC, Muecke HW, Joiner TA, Pope WT, Haider SC. Immunogenicity of low-dose intradermal recombinant DNA hepatitis B vaccine. Southern Medical Journal 1991;84:426–430.
7. Wistrom J, Settergren B, Gustafsson A, Juto P, Norrby RS. Intradermal versus intramuscular hepatitis B vaccination. JAMA 1990;264:181–182.
8. Redfield RR, Innis BL, Scott RM, Cannon HG, Bancroft WH. Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine: a cost strategy. JAMA 1985;254:3203–3206.
9. Prasetya E, Linggadjaja W, Syambali R, Kusumo S, Dharmesetyawan DF, Rahardja U. Intradermal vaccination against hepatitis B in Immanuel Hospital personnel–a preliminary report. Ann Academic Medicine 1986;15:153–157.
10. Halsey NA, Reppert EJ, Margolis HS, Francis DP, Fields HA. Intradermal hepatitis B vaccination in an abbreviated schedule. Vaccine 1986;4:228–232.
11. Wahl M, Hermodsson S. Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response. Scandinavian Journal of Infectious Diseases 1987;19:617–621.
12. Gonzalez ML, Usandizaga M, Alomar P, Salva F, Martin F, Erroz MJ, et al. Intradermal and intramuscular route for vaccination against hepatitis B. Vaccine 1990;8:402–404.
13. Bryan JP, Sjogren MH, Perine PL, Legters LJ. Low-dose intradermal and intramuscular vaccination against hepatitis B. Clin Infect Dis 1991;14:697–707.
14. Hadler SC, Francis DP, Maynard JE, Thompson SE, Judson FN, Echenberg DF, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986;315: 209–214.
15. Barnes GP, Hanacik LJ. Hepatitis B Vaccine: persistence of antibody following immunization. Infect Control Hosp Epidemiol 1988;9:147–150.
16. McKinney WP, Horowitz M, Battiola R, Russler S. Duration of response to intramuscular versus low-dose intradermal hepatitis B booster vaccination. ICAAC. Houston, TX; September 1989;17:131. Abstract 181.
17. West DJ. Clinical experience with hepatitis B vaccine. Am J Infect Control 1989;17:172–180.
18. Centers for Disease Control. Update on hepatitis B prevention. MMWR 1987;36:353–366.
19. Szmuness W, Stevens CE, Harley EJ. Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection. N Engl J Med 1982;307:1481–1486.
20. Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptovax B): a final report. Hepatology 1981;1:377–385.
21. Krugman S, Davidson M. Hepatitis B vaccine: prospects for duration of immunity. Yale Journal of Biological Medicine 1987;60:333–338.